1. Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study. Issue 6 (June 2022) Authors: Taha, Taha E; Yende-Zuma, Nonhlanhla; Brummel, Sean S; Stranix-Chibanda, Lynda; Wambuzi Ogwang, Lillian; Dadabhai, Sufia; Chinula, Lameck; Nyati, Mandisa M; Hanley, Sherika; Makanani, Bonus; Chipato, Tsungai; Atuhaire, Patience; Aizire, Jim; Fowler, Mary Glenn Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 10281 (3rd April 2021) Authors: Lockman, Shahin; Brummel, Sean S; Ziemba, Lauren; Stranix-Chibanda, Lynda; McCarthy, Katie; Coletti, Anne; Jean-Philippe, Patrick; Johnston, Ben; Krotje, Chelsea; Fairlie, Lee; Hoffman, Risa M; Sax, Paul E; Moyo, Sikhulile; Chakhtoura, Nahida; Stringer, Jeffrey SA; Masheto, Gaerolwe; Korutaro, Vi... Journal: Lancet Issue: Volume 397:Issue 10281(2021) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial. Issue 5 (May 2022) Authors: Madhi, Shabir A; Moodley, Dhayendre; Hanley, Sherika; Archary, Moherndran; Hoosain, Zaheer; Lalloo, Umesh; Louw, Cheryl; Fairlie, Lee; Fouche, Leon Frederik; Masilela, Mduduzi S L; Singh, Nishanta; Grobbelaar, Coert; Ahmed, Khatija; Benadé, Gabriella; Bhikha, Sutika; Bhorat, As'ad Ebrahim; Bhorat... Journal: Lancet Issue: Volume 9:Issue 5(2022) Page Start: e309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neurodevelopmental outcomes of HIV/antiretroviral drug perinatally exposed uninfected children aged 3–6 years. (1st September 2022) Authors: Fowler, Mary Glenn; Hanrahan, Colleen; Yende, Nonhlanhla; Stranix-Chibanda, Lynda; Chipato, Tsungai; Maliwichi, Limbika; Gadama, Luis; Aizire, Jim; Dadabhai, Sufia; Chinula, Lameck; Wambuzi-Owang, Lillian; Owor, Maxensia; Violari, Avy; Nyati, Mandisa; Hanley, Sherika; Govender, Vani; Brummel, Sea... Journal: AIDS Issue: Volume 36:Number 11(2022) Page Start: 1533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial. Issue 5 (May 2022) Authors: Ruel, Theodore D; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen; Montañez, Nicole; Popson, Stephanie; Buchanan, Ann M; Bartlett, Mattie; Dayton, Dale; Anthony, Patricia; Brothers, Cynthia; Vavro, Cynthia; Singh, Rajendra; Koech, Lucy; Vhembo, Tichaona; Mmbaga, Blandina T; Pi... Journal: Lancet Issue: Volume 9:Issue 5(2022) Page Start: e332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗